- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
- Clinical Trials Update — A table of past, current and planned vaccine trials
- The Years Ahead in Biomedical HIV Prevention — A timeline graphic of expected trial results and potential regulatory submission for the range of products being tested, including vaccine candidates
- HVTN 702 Updates and Next Steps — Leaders of HVTN 702 HIV vaccine efficacy trial in South Africa, announced that vaccinations would be stopped early because the vaccine candidate did not prevent HIV.
- Global HIV Prevention R&D Investment by Technology — This website from the HIV Prevention Research & Development Working Group shows investment trends in HIV prevention.